Anaïs Glatard, PhD

  • 2Articles
  • 6.5KReads
  • 2019–2020Active
  • 18Collaborators
  • 19Citations

About

Anaïs Glatard, PhD, has published research focusing on metabolic disorders and schizophrenia/schizoaffective disorders. Their work includes evaluating cardiometabolic risk in large psychiatric cohorts and investigating lipid disturbances in adolescents treated with second-generation antipsychotics. Glatard's publications appeared between 2019 and 2020 in Psychiatrist.com. Frequent collaborators include Aurélie Delacrétaz, Céline Dubath, Chin B. Eap, Philippe Conus, and Alessandra Solida.

Publications

JCP
Original Research

Cardiometabolic Health in Psychiatry

March 31, 2020

Psychiatric patients are susceptible to cardiovascular disease (CVD), but this risk is poorly understood. This study compared CVD risk in psychiatric patients taking weight gain-inducing drugs with that in...
, , , et al
JCP
Original Research

Lipid Worsening in Adolescents Treated With SGAs

April 9, 2019

How bad is too bad? Lipid worsening of 5% or more in the early stages of treatment with SGAs predicts a negative metabolic outcome in adults. Is it the...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe